CrushSCI.com
71.1Average days
68Median days
23Fastest days
114Longest days
2002025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

79 days

Cost-consequence analysis of long peripheral catheters versus midline catheters: a post-hoc model-based analysis of published systematic review data

Authors
Davide Giustivi; Antonio Gidaro; Marco Gemma; Stefano Elli; Daniele Privitera; Adam FabianiShow moreShow less
Affiliations
1. Vascular Access Team ASST Lodi; 2. Department of Internal Medicine, “Luigi Sacco” Hospital, ASST-FBF-Sacco; 3. Neuroanesthesia & Intensive Care Foundation IRCCS, Neurological Institute “C. Besta”; 4. Vascular Access Team IRCCS San Gerardo dei Tintori Foundation; 5. Department of Health, Medicine and Life Sciences, Faculty of Science, Technology and Medicine, University of Luxembourg; 6. Cardiac Surgery Intensive Care Unit, Vascular Access Team, Azienda Sanitaria Universitaria Giuliano-IsontinaShow moreShow less
Source PDF DOI Publisher page
102 days

Comparison of 1-year costs of commercially insured patients with severe aortic stenosis undergoing surgical vs. transcatheter aortic valve replacement

Authors
Suzanne J. Baron; Benjamin Z. Galper; Marcella A. Kelley; Soumya G. Chikermane; Shannon M. E. MurphyShow moreShow less
Affiliations
1. Division of Cardiology, Massachusetts General Hospital; 2. Baim Institute for Clinical Research; 3. Mid-Atlantic Permanente Medical Group; 4. Edwards LifeSciencesShow moreShow less
Source PDF DOI Publisher page
23 days

Uncovering the full economic impact of biosimilars: a “would have spent” counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016–2025

Authors
Seungjae Yi; Minyoung Jang; Federico Di Biasio; Dongkyu Kim; Taek Sang Kwon; Jooyeop Lee; Jihyun Lee; Anja Tuomioja-Busk; Nicolas Van GelderShow moreShow less
Affiliations
1. Market Access Celltrion, Inc; 2. Commercial, Celltrion Healthcare Italy SRL; 3. Commercial and Market Access, Celltrion Healthcare France SAS; 4. Global Marketing, Celltrion, Inc; 5. Commercial and Market Access, Celltrion Healthcare Finland; 6. Commercial and Market Access, Celltrion Healthcare BelgiumShow moreShow less
Source PDF DOI Publisher page
68 days

Evaluating the cost-effectiveness of enhanced cardiovascular-renal-metabolic (CVRM) screening in UK, France, Germany and Australia: a microsimulation-based enhanced CVRM screening analysis

Authors
Fiona Adshead; Georgios Xydopoulos; Vasileios Vasilopoulos; Alexandre Babin; Amitava Banerjee; Bruno Detournay; Jamie Espín; Ines Hassan; Matt Kearney; Jan T. Kielstein; Koichiro Kuwahara; Nirosha Lederer; Carel W. le Roux; Natalie Raffoul; Lise Retat; Scott B. Robinson; Andrew Sindone; Juergen Wasem; Clélia-Elsa FroguelShow moreShow less
Affiliations
1. Sustainable Healthcare Coalition; 2. ZS; 3. Renaloo; 4. University College London Hospitals; 5. CEMKA; 6. Andalusian School of Public Health/Escuela Andaluza de Salud Pública (EASP); 7. CIBER en Epidemiologíay Salud Pública (CIBERESP), Spain/CIBER of Epidemiology and Public Health (CIBERESP), Spain; 8. Instituto de Investigación Biosanitaria ibs.GRANADA; 9. Praxis Health Consulting; 10. CVDACTION; 11. Universität Braunschweig; 12. Shinshu University School of Medicine; 13. Global Policy Evidence, Global Medical Evidence, Biopharmaceuticals Medical, AstraZeneca; 14. UNC Eshelman School of Pharmacy; 15. Diabetes Complications Research Centre, University College; 16. Diabetes Research Center, Ulster University; 17. National Heart Foundation; 18. Global Centre of Excellence, AstraZeneca; 19. Formerly Affiliated with ZS; 20. Concord and Ryde Hospitals, University of Sydney; 21. University Duisburg; 22. Global Policy, Advocacy and Health Equity, AstraZenecaShow moreShow less
Source PDF DOI Publisher page
50 days

Real-world utilization of gonadotropins and the associated cumulative live birth rates in the United States: a retrospective claims database analysis

Authors
Weiguang Xue; Emily Jungheim; Min Yang; Sanghyuk Seo; Lindsay Kelly; Wei ZhouShow moreShow less
Affiliations
1. Analysis Group, Ltd; 2. Northwestern University Feinberg School of Medicine; 3. Analysis Group, Inc; 4. Ferring Pharmaceuticals, IncShow moreShow less
Source PDF DOI Publisher page
98 days

Healthcare utilization and costs associated with dextromethorphan-bupropion versus selected other branded treatments for major depressive disorder: a US real-world study

Authors
Leslie Citrome; Yang Zhao; Courtney Zeni; Nicole Princic; Megan Richards; Shawn P. Alter; Andrew J. CutlerShow moreShow less
Affiliations
1. New York Medical College; 2. Axsome Therapeutics, Inc; 3. Merative; 4. SUNY Upstate Medical University; 5. Neuroscience Education InstituteShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does JOURNAL OF MEDICAL ECONOMICS take to review a manuscript?

As of 2026-11-19, CrushSCI has 21 complete review records for JOURNAL OF MEDICAL ECONOMICS. The fastest paper went from submission to acceptance in 23 days (Uncovering the full economic impact of biosimilars: a “would have spent” counterfactual analysis of five reference biologics (infliximab, adalimumab, bevacizumab, rituximab, and trastuzumab) in the United States and Europe, 2016–2025, received 2026-09-15, accepted 2026-10-08); the slowest took 114 days. The average is 71.1 days and the median is 68 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.